Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Furoate in Persistent Mild-Moderate Asthma
NCT00687531Phase 4Terminated
- Sponsor
- Organon & Co.
- Start
- Nov 2006
- Primary completion
- Sep 2009
- Modality
- Orthosteric Ligands
01
Overview
Phase 4, open-label, single-arm trial of mometasone in asthma, sponsored by Organon & Co. Primary endpoint: Forced Expiratory Volume in 1 Second at Week 12. Started Nov 2006; status: terminated.
02
Drugs
mometasone
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00687531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00687531.